Lithium Ion

Lithium Ion

SCHEMBL5017041

O=C(O)C(=O)OC(=O)C(F)(F)S(=O)(=O)O.O=C(O)C(=O)OC(=O)C(F)(F)S(=O)(=O)O.O=C(O)C(=O)OC(=O)C(F)(F)S(=O)(=O)O.[Li+].[Li+].[Li+].[O-]B([O-])[O-]

nearest known ligand 0.42

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

GSK3AGSK3BIMPA1

The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5017092 0.85 ALDH1A1 (0.33) ALDH1A1L3MBTL1
Boric Acid SCHEMBL15473541 0.79 ALDH1A1 (0.38) ALDH1A1L3MBTL1
SCHEMBL5015071 0.74
SCHEMBL10265411 0.70 ALDH1A1 (0.40) ALDH1A1L3MBTL1
Oxalic Acid SCHEMBL5013712 0.70 ALDH1A1 (0.42) ALDH1A1L3MBTL1
SCHEMBL27487352 0.67
SCHEMBL13195579 0.66 ALDH1A1 (0.48) ALDH1A1L3MBTL1
SCHEMBL7838132 0.65 ALDH1A1 (0.52) ALDH1A1L3MBTL1
SCHEMBL24107527 0.63 ALDH1A1 (0.50) ALDH1A1L3MBTL1
SCHEMBL19605045 0.63 ALDH1A1 (0.50) ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080118845-A1 IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY SONY CORPORATION (JP) 2008-05-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080118845-A1 IONIC COMPOUND, ELECTROLYTIC SOLUTION, ELECTROCHEMICAL DEVICE, AND BATTERY CA2, DUOX2, OTC ALDH1A1 2771/4885L3MBTL1 1478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.